Thiamidol: A Breakthrough Innovation in the Treatment of Hyperpigmentation
Journal of Drugs in Dermatology · 2025
DOI: 10.36849/jdd.9093 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Drugs in Dermatology, 2025. Verfasst von Cheri Frey und 8 weiteren Autor:innen. Hauptthemen laut MEDLINE: Hyperpigmentation, Monophenol Monooxygenase, Resorcinols. Die Arbeit wurde bisher 8-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Frey, C., Grimes, P., Callender, V. D., Alexis, A., Baldwin, H., Elbuluk, N., Farris, P., Taylor, S., & Desai, S. R. (2025). Thiamidol: A Breakthrough Innovation in the Treatment of Hyperpigmentation. Journal of Drugs in Dermatology. https://doi.org/10.36849/jdd.9093
Vancouver
Frey C, Grimes P, Callender VD, Alexis A, Baldwin H, Elbuluk N, et al. Thiamidol: A Breakthrough Innovation in the Treatment of Hyperpigmentation. Journal of Drugs in Dermatology. 2025. doi:10.36849/jdd.9093
BibTeX
@article{Frey2025,
author = {Frey, Cheri and Grimes, Pearl and Callender, Valerie D and Alexis, Andrew and Baldwin, Hilary and Elbuluk, Nada and Farris, Patricia and Taylor, Susan and Desai, Seemal R},
title = {Thiamidol: A Breakthrough Innovation in the Treatment of Hyperpigmentation},
journal = {Journal of Drugs in Dermatology},
year = {2025},
doi = {10.36849/jdd.9093}
}
EUVIMED